查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572953

性传染病检查市场:全球产业分析，规模，占有率，成长，趋势，预测，2024年～2031年

Sexually Transmitted Disease Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 179 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球性传染病 (STD) 检测市场的综合报告，深入分析了关键市场动态，包括市场推动因素、趋势、机会和挑战。该报告提供了有关当前市场结构和未来成长前景的宝贵见解，以帮助利害关係人做出明智的决策。

主要的洞察

  • 性传染病检测市场规模（2024 年）：100.3 亿美元
  • 预测市场规模（2031 年）：170.8 亿美元
  • 全球市场成长率（2024-2031 年复合年增长率）：7.9%

性病检测市场：调查范围

STD 检测市场包括 HIV、梅毒、淋病、披衣菌和人类乳突病毒 (HPV) 等性传染病的诊断检测。性传染感染盛行率的增加、公众健康意识的提高以及获得医疗保健服务的机会的改善是推动性传染感染检测需求的关键因素。该市场还包括各种测试方法，例如基于实验室的测试、现场护理测试和快速诊断。自检套件的接受度不断提高以及诊断工具的技术进步进一步推动了市场的成长。

推动市场成长的因素：

有几个因素正在推动全球性病检测市场的成长。人们对性健康的认识不断提高，政府加大了预防性传染病的力度，以及性传染病发生率的上升是关键因素。此外，不断扩大的医疗基础设施、先进诊断工具的可用性以及对性传染病早期检测和治疗的需求不断增加也在推动市场成长。此外，融合远距医疗和数位健康平台的检测和咨询服务正在进一步加速市场推广。

市场阻碍因素：

儘管性病检测市场有着积极的成长前景，但它仍面临着一些挑战。在某些地区，社会耻辱和对性传染病缺乏认识阻碍了广泛的检测。资金不足的环境也面临着检测服务的有限性以及与某些诊断方法相关的高成本的挑战。区域监管差异和对专业医疗基础设施的需求也可能限制某些地区的市场成长。

市场机会：

由于诊断技术的进步和对自我检测试剂盒的需求增加，性传染病检测市场提供了巨大的成长机会。快速现场诊断测试和家庭测试解决方案的发展正在为市场扩张开闢新途径。医疗保健提供者、诊断公司和公共卫生组织之间的合作可以进一步增强检测范围和可近性。此外，增加对性健康意识活动和研究措施的投资，以遏制性传染病的传播，正在为该市场的公司创造新的成长机会。

本报告解决的关键问题

  • 推动性病检测市场全球成长的关键因素是什么？
  • 哪些地区和市场领域对性病检测服务的需求最高？
  • 诊断技术的进步如何影响性传染病检测市场的竞争格局？
  • 谁是性传染病检测市场的主要参与者？ 他们采取了哪些策略来维持自己的市场地位？
  • 全球性病检测市场的新趋势与未来前景如何？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围和定义
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
    • 课题
    • 主要的趋势
  • 宏观经济要素
    • 全球GDP成长展望
    • 全球医疗保健费支出展望
  • COVID-19影响分析
  • 预测要素 - 相关性及影响

第3章 附加价值的洞察

  • 产品采用分析
  • 疾病流行病学
  • 法规情形
  • 价值链分析
  • 主要的交易与合併
  • 大环境分析
  • 波特的五力分析

第4章 全球性传染病检查市场展望:实际成果(2019年～2023年)与预测(2024年～2031年)

  • 全球性传染病检查市场展望:产品
    • 简介/主要调查结果
    • 过去的市场规模(一百万美元)分析，各产品，2019年～2023年
    • 目前市场规模(一百万美元)分析与预测，各产品，2024年～2031年
      • 设备·服务
      • 消耗品
      • 软体
  • 市场魅力分析:产品
  • 全球性传染病检查市场展望:用途
    • 简介/主要调查结果
    • 过去的市场规模(一百万美元)分析，各用途，2019年～2023年
    • 目前市场规模(一百万美元)分析与预测，各用途，2024年～2031年
      • CT/NG检验
      • 梅毒检验
      • HSV检验
  • 市场魅力分析:用途
  • 全球性传染病检查市场展望:技术
    • 简介/主要调查结果
    • 过去的市场规模(一百万美元)分析，各技术，2019年～2023年
    • 目前市场规模(一百万美元)分析与预测，各技术，2024年～2031年
      • 免疫检测
      • 分子诊断
  • 市场魅力分析:技术

第5章 全球性传染病检查市场展望:地区

  • 主要的亮点
  • 过去的市场规模(一百万美元)分析，各地区，2019年～2023年
  • 目前市场规模(一百万美元)分析与预测，各地区，2024年～2031年
    • 北美
    • 欧洲
    • 东亚
    • 南亚·大洋洲
    • 南美
    • 中东·非洲
  • 市场魅力分析:地区

第6章 北美的性传染病检查市场展望:实际成果(2019年～2023年)与预测(2024年～2031年)

第7章 欧洲的性传染病检查市场展望:实际成果(2019年～2023年)与预测(2024年～2031年)

第8章 东亚的性传染病检查市场展望:实际成果(2019年～2023年)与预测(2024年～2031年)

第9章 南亚·大洋洲的性传染病检查市场展望:实际成果(2019年～2023年)与预测(2024年～2031年)

第10章 南美的性传染病检查市场展望:实际成果(2019年～2023年)与预测(2024年～2031年)

第11章 中东·非洲的性传染病检查市场展望:实际成果(2019年～2023年)与预测(2024年～2031年)

第12章 竞争情形

  • 市场占有率分析，2024年
  • 市场结构
    • 竞争激烈化地图:各市场
    • 竞争仪表板
  • 企业简介(详细内容 - 概要，财务，策略，最近的趋势)
    • BD
    • F. Hoffmann-La Roche Ltd
    • Hologic Inc.
    • Abbott
    • Cepheid(Danaher)
    • Qiagen
    • OraSure Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Thermo Fisher Scientific, Inc.
    • Seegene Inc.
    • DiaSorin SPA
    • 其他

第13章 附录

  • 调查手法
  • 调查的前提条件
  • 缩写和简称
简介目录
Product Code: PMRREP34842

Persistence Market Research has recently released a comprehensive report on the global Sexually Transmitted Disease (STD) Testing Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This report offers valuable insights into the current market structure and future growth prospects, aiding stakeholders in making informed decisions.

Key Insights:

  • STD Testing Market Size (2024E): US$10.03 Bn
  • Projected Market Value (2031F): US$17.08 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 7.9%

STD Testing Market - Report Scope:

The STD Testing market includes diagnostic tests for sexually transmitted infections such as HIV, syphilis, gonorrhea, chlamydia, and human papillomavirus (HPV). The growing prevalence of STDs, increased public health awareness, and improved access to healthcare services are key factors driving the demand for STD testing. This market also includes various testing methods such as laboratory-based testing, point-of-care testing, and rapid diagnostics. The increasing acceptance of self-testing kits and technological advancements in diagnostic tools further support market growth.

Market Growth Drivers:

Several factors are driving the growth of the global STD Testing market. Rising awareness about sexual health, increased government initiatives for STD prevention, and growing incidences of sexually transmitted infections are key contributors. The expansion of healthcare infrastructure, the availability of advanced diagnostic tools, and increasing demand for early detection and treatment of STDs also propel market growth. Additionally, the integration of telemedicine and digital health platforms for testing and consultation services is further accelerating market adoption.

Market Restraints:

Despite the positive growth outlook, the STD Testing market faces several challenges. Social stigma and lack of awareness about STDs in certain regions hinder testing adoption. In low-resource settings, limited access to testing services and high costs associated with some diagnostic procedures also pose challenges. The variation in regulations across regions and the need for specialized healthcare infrastructure may also restrict market growth in some areas.

Market Opportunities:

The STD Testing market offers significant opportunities for growth, driven by advancements in diagnostic technologies and increasing demand for self-testing kits. The development of rapid point-of-care diagnostic tests and home-based testing solutions are opening new avenues for market expansion. Collaborations between healthcare providers, diagnostic companies, and public health organizations can further enhance testing outreach and accessibility. Additionally, rising investments in sexual health awareness campaigns and research initiatives to combat the spread of STDs present new growth opportunities for companies in this market.

Key Questions Answered in the Report:

  • What are the primary factors driving the global growth of the STD Testing market?
  • Which regions and market segments are experiencing the highest demand for STD testing services?
  • How are technological advancements in diagnostics impacting the competitive landscape of the STD Testing market?
  • Who are the major players in the STD Testing market, and what strategies are they employing to maintain their market positions?
  • What are the emerging trends and future outlooks for the global STD Testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global STD Testing market, including Abbott Laboratories, F. Hoffmann-La Roche Ltd, and bioMerieux SA, are focusing on technological innovation, expanding their product portfolios, and forming strategic partnerships to strengthen their market positions. These companies are investing in the development of advanced diagnostic tools, such as rapid tests and molecular diagnostics, to meet the growing demand for accurate and timely STD testing. Collaborations with healthcare providers, public health organizations, and government bodies are essential for increasing testing accessibility and promoting early detection initiatives.

Key Companies Profiled:

  • BD
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc.
  • Abbott
  • Cepheid (Danaher)
  • Qiagen
  • OraSure Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Thermo Fisher Scientific, Inc.
  • Seegene Inc.
  • DiaSorin S.P.A

STD Testing Industry Research by Category:

By Product

  • Instruments & Services
  • Consumables
  • Software

By Application

  • CT/NG Testing
  • Syphilis Testing
  • HSV Testing

By Technology

  • Immunoassay
  • Molecular Diagnostics

By Region

  • North America
  • Latin America
  • Europe
  • South Asia & Oceania
  • East Asia
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Sexually Transmitted Disease Testing Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Growth Outlook
    • 2.3.2. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Disease Epidemiology
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Global Sexually Transmitted Disease Testing Market Outlook: Product
    • 4.1.1. Introduction / Key Findings
    • 4.1.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2023
    • 4.1.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
      • 4.1.3.1. Instruments & Services
      • 4.1.3.2. Consumables
      • 4.1.3.3. Software
  • 4.2. Market Attractiveness Analysis: Product
  • 4.3. Global Sexually Transmitted Disease Testing Market Outlook: Application
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
      • 4.3.3.1. CT/NG Testing
      • 4.3.3.2. Syphilis Testing
      • 4.3.3.3. HSV Testing
  • 4.4. Market Attractiveness Analysis: Application
  • 4.5. Global Sexually Transmitted Disease Testing Market Outlook: Technology
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By Technology, 2019-2023
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
      • 4.5.3.1. Immunoassay
      • 4.5.3.2. Molecular Diagnostics
  • 4.6. Market Attractiveness Analysis: Technology

5. Global Sexually Transmitted Disease Testing Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By Application
    • 6.3.4. By Technology
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 6.4.1. U.S.
    • 6.4.2. Canada
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
    • 6.5.1. Instruments & Services
    • 6.5.2. Consumables
    • 6.5.3. Software
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 6.6.1. CT/NG Testing
    • 6.6.2. Syphilis Testing
    • 6.6.3. HSV Testing
  • 6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
    • 6.7.1. Immunoassay
    • 6.7.2. Molecular Diagnostics
  • 6.8. Market Attractiveness Analysis

7. Europe Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Application
    • 7.3.4. By Technology
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. U.K.
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Russia
    • 7.4.7. Turkiye
    • 7.4.8. Rest of Europe
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
    • 7.5.1. Instruments & Services
    • 7.5.2. Consumables
    • 7.5.3. Software
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 7.6.1. CT/NG Testing
    • 7.6.2. Syphilis Testing
    • 7.6.3. HSV Testing
  • 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
    • 7.7.1. Immunoassay
    • 7.7.2. Molecular Diagnostics
  • 7.8. Market Attractiveness Analysis

8. East Asia Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Application
    • 8.3.4. By Technology
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. South Korea
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
    • 8.5.1. Instruments & Services
    • 8.5.2. Consumables
    • 8.5.3. Software
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 8.6.1. CT/NG Testing
    • 8.6.2. Syphilis Testing
    • 8.6.3. HSV Testing
  • 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
    • 8.7.1. Immunoassay
    • 8.7.2. Molecular Diagnostics
  • 8.8. Market Attractiveness Analysis

9. South Asia & Oceania Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Application
    • 9.3.4. By Technology
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 9.4.1. India
    • 9.4.2. Southeast Asia
    • 9.4.3. ANZ
    • 9.4.4. Rest of South Asia & Oceania
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
    • 9.5.1. Instruments & Services
    • 9.5.2. Consumables
    • 9.5.3. Software
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 9.6.1. CT/NG Testing
    • 9.6.2. Syphilis Testing
    • 9.6.3. HSV Testing
  • 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
    • 9.7.1. Immunoassay
    • 9.7.2. Molecular Diagnostics
  • 9.8. Market Attractiveness Analysis

10. Latin America Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Application
    • 10.3.4. By Technology
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 10.4.1. Brazil
    • 10.4.2. Mexico
    • 10.4.3. Rest of Latin America
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
    • 10.5.1. Instruments & Services
    • 10.5.2. Consumables
    • 10.5.3. Software
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 10.6.1. CT/NG Testing
    • 10.6.2. Syphilis Testing
    • 10.6.3. HSV Testing
  • 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
    • 10.7.1. Immunoassay
    • 10.7.2. Molecular Diagnostics
  • 10.8. Market Attractiveness Analysis

11. Middle East & Africa Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Application
    • 11.3.4. By Technology
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 11.4.1. GCC Countries
    • 11.4.2. Egypt
    • 11.4.3. South Africa
    • 11.4.4. Northern Africa
    • 11.4.5. Rest of Middle East & Africa
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
    • 11.5.1. Instruments & Services
    • 11.5.2. Consumables
    • 11.5.3. Software
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 11.6.1. CT/NG Testing
    • 11.6.2. Syphilis Testing
    • 11.6.3. HSV Testing
  • 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
    • 11.7.1. Immunoassay
    • 11.7.2. Molecular Diagnostics
  • 11.8. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. BD
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. F. Hoffmann-La Roche Ltd
    • 12.3.3. Hologic Inc.
    • 12.3.4. Abbott
    • 12.3.5. Cepheid (Danaher)
    • 12.3.6. Qiagen
    • 12.3.7. OraSure Technologies, Inc.
    • 12.3.8. Bio-Rad Laboratories, Inc.
    • 12.3.9. bioMerieux SA
    • 12.3.10. Thermo Fisher Scientific, Inc.
    • 12.3.11. Seegene Inc.
    • 12.3.12. DiaSorin S.P.A
    • 12.3.13. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations